Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for endometriosis pain: drug HMI-115 tested in 142 women

NCT ID NCT05101317

First seen Nov 18, 2025 · Last updated May 23, 2026 · Updated 28 times

Summary

This study tested a drug called HMI-115 against a placebo in 142 women with moderate to severe endometriosis pain. The goal was to see if the drug safely reduces pain over 12 weeks. Participants had to have a confirmed endometriosis diagnosis and report significant pain.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Instytut Matki i Dziecka

    Warsaw, Masovian Voivodeship, Poland

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, 100703, China

  • Physicians' Research Options, LLC- Corner Canyon Clinic

    Draper, Utah, 84020, United States

  • Specjalistyczna Poradnia Ginekologiczna Gabinet Ginekologiczny Dr med. Janusza Tomaszewskiego

    Bialystok, Podlaskie Voivodeship, Poland

  • Tidewater Clinical Research/TPW

    Norfolk, Virginia, 23502, United States

Conditions

Explore the condition pages connected to this study.